Bausch Health Provides Company Update At 18th Annual Morgan Stanley Global Healthcare Conference
LAVAL, Quebec, Sept. 16, 2020 /CNW/ — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health” or the “Company”) today announced it has published a presentation that Joseph C. Papa, chairman and CEO, and Paul S. Herendeen, executive vice president and chief financial officer, are scheduled to present at the virtual 18th Annual Morgan Stanley Global Healthcare Conference today, Sept. 16, 2020, at 1:15 p.m. ET.
The presentation provides an update on Bausch Health’s current business recovery in the wake of the COVID-19 pandemic, as well as an update and progress report regarding the Company’s previously disclosed intention to spin off its eye health business.
http://ir.bauschhealth.com/events-and-presentations/2020. A live webcast and audio archive of the event will be also be available for 90 days. ” data-reactid=”14″>The presentation is available on the Investor Relations page of the Bausch Health Companies Inc. web site at: http://ir.bauschhealth.com/events-and-presentations/2020. A live webcast and audio archive of the event will be also be available for 90 days.
www.bauschhealth.com.” data-reactid=”19″>About Bausch Health
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people’s lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. More information can be found at www.bauschhealth.com.
